Document is current
Any future updates will be listed below
-
Authors
Antinori, A.
Vergori, A.
Ripamonti, D.
Valenti, D.
Esposito, V.
Carleo, M. A.
Rusconi, S.
Cascio, A.
Manzillo, E.
Andreoni, M.
Orofino, G.
Cappuccio, A.
Reale, L.
Marini, M. G.
Mancusi, D.
Termini, R.
Uglietti, A.
Portaro, M.
- License Information
-
More Information
Article History
Received: 5 April 2023
Accepted: 12 October 2023
First Online: 17 October 2023
Competing interests
: AA had financial relationship with Astrazeneca, Gilead Sciences, Glaxo Smith Kline, Janssen, Merck, Roche, Theratechnologies, ViiV Healthcare. AV had financial relationship with Janssen-Cilag, ViiV Healthcare srl, MSD, Gilead. DR had financial relationship with Janssen, Gilead, ViiVhealthcare. VE had financial relationship with Gilead Sciences, MSD, Theratechnologies, ViiV Healthcare. MAC had financial relationship with MSD, Janssen-Cilag spa,ViiV Healthcare srl. SR had financial relationship with Gilead Sciences, Glaxo Smith Kline, Janssen, MSD, Theratechnolo-gies, ViiV Healthcare. MA had financial relationship with ViiV Healthcare srl, MSD, Gilead, GSK, Pfizer, Angelini, Janssen Tibotec. AC, LR, MGM are employee of ISTUD. MP, UA, TR, MD are employee of Janssen-Cilag Spa. DV, AC, EM and GO has none to declare.
